The potential of microRNAs in liver fibrosis. Cellular Signalling 2012;24:2268-2272.He, Y.; Huang, C.; Zhang, S.P.; Sun, X.; Long, X.R.; Li, J. The potential of microRNAs in liver fibrosis. Cell Signal 2012, 24, 2268-2272. [CrossRef] [PubMed]...
Microvesicles (MVs) are 0.1–1.0 μm vesicles containing lipids, proteins, RNAs and microRNAs; they are formed by budding from the cellular plasma membrane Circulating levels of several subpopulations of MVs are increased in patients with liver diseases, probably due to enhanced MV production and de...
Understanding the potential role of nanotechnology in liver fibrosis: a paradigm in therapeutics Molecules, 28 (6) (2023), p. 2811 CrossrefView in ScopusGoogle Scholar Cited by (2) Novel microwave assisted carboxymethyl-graphene oxide and its hepatoprotective activity 2024, BMC Pharmacology and Toxic...
MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies Article Open access 10 July 2023 Multifaceted role of microRNA-301a in human cancer: from biomarker potential to therapeutic targeting Article 24 September 2024 References Bartel, D. P. MicroRNAs: genomics, biogenesi...
MicroRNAs (miRNAs) are epigenetic regulators of the gene expression and act through posttranslational modification. They bind to 3′-UTR of target mRN
Targeting microRNAS for the treatment of liver cancer$%^&*AU2014271307A120150115.pdf### TARGETING MICRORNAS FOR THE TREATMENT OF LIVER CANCER Abstract: Provided herein are methods for the treatment of liver cancer. These methods encompass the administration of a compound comprising a modified oligonu...
Provided herein are methods for the treatment of liver cancer. These methods encompass the administration of a compound comprising a modified oligonucleotide, wherein the modified oligonucleotide is targeted to a miRNA. Also provided herein are compositions for the treatment of liver cancer. Such ...
As the primary pathological manifestation in CKD, renal fibrosis is often used as a critical target for the treatment of CKD and inhibits the progression of CKD to end-stage renal disease (ESRD). As a potential drug, natural products have been confirmed to have the potential as a routine or...
These results indicate the dual and complicated role of FGF19 in HCC development, and point towards screening of potential risk factors before adjusting FGF19 expression for HCC treatment. These results were also verified in animal experiments in nonalcoholic fatty liver disease.8 Meanwhile, patients...
Modulation of MicroRNAs as a Potential Molecular Mechanism Involved in the Beneficial Actions of Physical Exercise in Alzheimer Disease by Alex Cleber Improta-Caria 1,2,3, Carolina Kymie Vasques Nonaka 3,4, Bruno Raphael Ribeiro Cavalcante 3,4,5, Ricardo Augusto Leoni De Sousa 6, Ro...